Screener Summaries Updates Institutions Sign In More Updates › Financing › NGEN Financing · Jul 2, 2026
NervGen Pharma Corp. entered into a Sales Agreement with Leerink Partners LLC on July 2, 2026 NGEN Nervgen Pharma Corp.
NervGen Pharma Corp. entered into a Sales Agreement with Leerink Partners LLC on July 2, 2026. The company operates in the biotechnology industry and develops therapies for neurodegenerative diseases.
More from Nervgen Pharma Corp. All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
